How to invest in ASML from India: Amsterdam line vs the US ADR

There is really only one reason most Indian investors look at the Netherlands at all, and its name is ASML. The company that builds the extreme-ultraviolet lithography machines without which no advanced chip gets made — the supplier that TSMC, Samsung, and Intel all depend on — is headquartered in Veldhoven and listed on Euronext Amsterdam. For anyone who wants direct exposure to the single most strategically important hardware company in the semiconductor supply chain, ASML is the position. The question is not usually whether to own it, but where to buy it from.

Because ASML trades in two places that an Indian investor can realistically reach: the home listing on Euronext Amsterdam (ticker ASML.AS, priced in euros) and the US-listed line on Nasdaq (ticker ASML, priced in dollars, structured as an American Depositary Receipt). They look interchangeable. They are not. The choice between them changes your dividend withholding paperwork, your currency exposure, your brokerage options, and — the part almost nobody flags — your exposure to US estate tax. This guide walks through both routes in the detail an Indian resident actually needs before placing the order.

The two listings, side by side

First, the basic shape of the choice. ASML is a single Dutch company with one pool of economic ownership; the Nasdaq line represents the same underlying ordinary shares, on a one-to-one basis. (Strictly, ASML's US line is structured as New York registry shares administered by a US transfer agent rather than a classic depositary-receipt ADR, but it trades like one and is loosely called an ADR; the one-to-one economic equivalence holds either way.) You are buying the same business and the same dividend either way. What differs is the wrapper around the shares and the jurisdiction your broker routes you through.

	Amsterdam line (ASML.AS)	US ADR (ASML)
Exchange	Euronext Amsterdam	Nasdaq
Currency	EUR	USD
Instrument	Ordinary share	Depositary receipt (1:1)
Underlying domicile	Netherlands	Netherlands
Dividend withholding	15% Dutch at source	15% Dutch, passed through
Situs for US estate tax	Not US-situs	Generally treated as US-situs
Typical India-facing broker	Interactive Brokers, Saxo	IBKR, plus US-stock apps

The headline takeaway is in the last two rows. The economics of the dividend are nearly identical across both lines because the tax that bites is Dutch, not American — ASML is a Dutch company, so its dividends carry Dutch withholding regardless of which exchange you hold the share on. But the situs differs, and that is where the two routes genuinely diverge for an Indian investor thinking about the long term.

Dividend withholding: the same 15%, taxed at source

ASML pays a real, growing dividend. The 2025 dividend approved at the April 2026 AGM came to roughly €7.50 per share. By big-tech standards the yield is modest — ASML is a growth-and-capex story far more than an income story — but it is not zero, and the withholding treatment matters for your annual tax filing.

The Netherlands levies a 15% statutory dividend withholding tax (dividendbelasting) on distributions from Dutch companies. This applies to ASML dividends whether you hold ASML.AS in Amsterdam or the ASML ADR on Nasdaq. On the ADR, the Dutch tax is withheld upstream and effectively passed through to you — the depositary bank handles the mechanics, but you still bear the 15% Dutch charge, not a US rate. This is the single most common misconception we see: investors assume that because the ADR trades in dollars on a US exchange, US dividend rules apply. They do not. The dividend is Dutch-source, and Dutch withholding governs it.

For a fuller treatment of the rate, the India–Netherlands treaty position, and why the much-discussed 5% figure does not apply, see our dedicated guide on Netherlands dividend withholding and the India DTAA. The short version: the treaty caps the rate at 10%, but the practical at-source deduction is 15%, and the gap is recoverable only through a slow Dutch reclaim — most retail investors instead lean on the Indian foreign tax credit.

Claiming the credit in India

Whichever line you hold, the 15% withheld in the Netherlands is not lost. As an Indian resident you can claim it as a foreign tax credit against your Indian tax on the same dividend, using Form 67 (being renumbered Form 44 from TY2026-27). The dividend itself is taxable in India at your slab rate; the FTC offsets the Dutch tax already paid, so you are not taxed twice on the same income. Our Form 67 FTC calculator helps you size the credit. The mechanics here are identical to how US stocks are taxed in India — only the source country and the headline rate change.

Where the routes truly diverge: US estate tax

Here is the consideration that should drive the decision for any Indian investor planning to hold ASML for years, and that almost no broker will raise with you.

A US-listed ADR is generally treated as a US-situs asset for US federal estate-tax purposes. The Amsterdam ordinary share is not. This is not a trivial distinction. For an Indian resident — a non-resident alien in US tax language — the US estate-tax exemption is a tiny $60,000, the top rate climbs to 40%, and there is no India–US estate-tax treaty to soften it. We covered the full mechanics in the $60,000 trap, and the logic carries straight over to Dutch ADRs.

Put plainly: if you build a large ASML position through the Nasdaq ADR, you may be quietly accumulating US-situs assets that — combined with any US stocks and US-domiciled ETFs you also hold — push you past the $60,000 line and into a potential 40% estate-tax exposure your heirs would have to deal with. If you build the same position through the Amsterdam line (ASML.AS), the share is a Dutch asset and sits entirely outside the US estate-tax net.

This single fact reverses the intuition most Indian investors start with. The ADR feels simpler — it trades in dollars, sits in the same app as your US stocks, and reads as "just another US ticker." But for a long-term holder, the Amsterdam line is structurally the cleaner choice precisely because it keeps ASML out of the US estate-tax system. The dividend treatment is the same; the estate exposure is not.

Note: estate-tax situs rules for ADRs of foreign companies are nuanced and the treatment can depend on the specific facts. The general position is that US-listed ADRs are US-situs, but if you intend to hold a very large position, confirm with a cross-border advisor rather than relying on a blog.

Currency: euros vs dollars (and rupees underneath)

The Amsterdam line is priced in euros; the ADR in US dollars. ASML's actual business — its revenues and its reported earnings — is largely euro-and-dollar denominated regardless, so this is mostly about which currency conversion sits between you and the share.

If you fund through an Indian rupee account and remit under the LRS, your money is converted to the listing currency at purchase and back to rupees on exit. Buying ASML.AS means an INR-to-EUR conversion; buying the ADR means INR-to-USD. Neither is inherently better — your real exposure is to the underlying business plus the EUR/INR or USD/INR cross. For most investors the spread difference is small. The one practical point: if the rest of your foreign portfolio is in dollars, the ADR keeps everything in a single currency bucket and slightly simplifies your mental accounting, while the Amsterdam line adds a euro sleeve. Weigh that minor convenience against the estate-tax point above — the estate-tax consideration is far larger.

Brokerage access and the LRS mechanics

To buy either line you remit funds abroad under the Liberalised Remittance Scheme, which allows an Indian resident to send up to $250,000 per financial year for permitted capital-account transactions including foreign equities.

• Amsterdam line (ASML.AS): You need a broker that offers Euronext Amsterdam access. Interactive Brokers is the standard route for Indian residents wanting direct European-exchange access; Saxo is another. The popular India-facing US-stock apps generally do not offer direct Amsterdam access — they are built around the US market.
• US ADR (ASML): Any broker that gives you US-market access can buy the ADR. That includes IBKR and the India fintech wrappers built around US investing. This is the lower-friction route for someone who already has a US brokerage relationship and nothing else.

On the LRS itself: remittances up to Rs 10 lakh in a financial year attract no TCS; above that, 20% TCS applies, which you can adjust against your tax liability or claim back. Model your year's remittances with our LRS / TCS calculator before you fund a large ASML purchase. And regardless of which line you choose, every foreign holding goes into Schedule FA of your Indian return each year — our Schedule FA helper handles the initial, peak, and closing-value math.

Capital gains: identical in India, near-zero at source

Good news on this front: capital gains treatment does not depend on which line you hold.

At source, the Netherlands does not tax a non-resident on gains from Dutch listed shares (other than substantial holdings, which a retail position will never be). So selling ASML.AS triggers no Dutch capital-gains tax. The US likewise generally does not tax a non-resident alien on US-market capital gains, so selling the ADR triggers no US capital-gains tax either. In both cases the gain is effectively untaxed at source.

The tax that matters is the Indian one, and it is the same whichever line you held:

• Long-term (held more than 24 months): 12.5%, with no indexation benefit.
• Short-term (held 24 months or less): taxed at your slab rate.

You can estimate the bill with our capital-gains calculator — the engine is built for US holdings but the Indian-side LTCG/STCG logic is identical for a Dutch share. The practical implication: hold ASML for at least two years and the gain is taxed at a flat 12.5% in India, which for most investors is the single biggest argument for treating it as a long-term core position rather than a trade.

Why investors want ASML in the first place

It is worth pausing on the investment case, because the situs and tax mechanics only matter if the stock earns a place in your portfolio at all.

ASML occupies a position almost unique in global equities: it is the sole supplier of extreme-ultraviolet (EUV) lithography machines, the multi-hundred-million-dollar systems required to manufacture the most advanced semiconductors. There is no second source. TSMC, Samsung, and Intel cannot make leading-edge chips without ASML's machines, which means ASML sits at a genuine choke point of the entire modern technology economy — every AI accelerator, every advanced smartphone processor, every cutting-edge data-centre chip traces back through ASML's equipment. That structural monopoly on the most advanced tooling is the heart of the bull case.

The flip side is that ASML is cyclical and concentrated. Its order book swings with the capital-expenditure cycles of a small number of chipmakers, and it is exposed to the geopolitics of semiconductor trade — export-control restrictions on sales to China have been a recurring overhang. The stock can be volatile, and its valuation often prices in a great deal of future growth. None of this makes it a bad holding; it makes it a concentrated, high-conviction one, best sized accordingly within a diversified portfolio rather than treated as a safe core.

For an Indian investor, the key point is that no broad index gives you ASML in concentrated form. Inside a global UCITS fund or the AEX index ETF (where the index applies a 15% per-name cap at each review), ASML is just one weighted name among many. If you have a specific conviction in the lithography-monopoly thesis, owning the stock directly is the only way to express it at meaningful weight — which is exactly why the Amsterdam-versus-ADR decision is worth getting right.

So which line should you actually buy?

Here is the decision framed the way we would frame it for ourselves.

Default to the Amsterdam line (ASML.AS) if you are a long-term holder. The dividend treatment is identical to the ADR, and the share sits outside US estate tax. For a position you intend to hold for years and pass on, that estate-tax cleanliness is worth the minor friction of needing a Euronext-capable broker and holding a euro sleeve.

Consider the US ADR (ASML) only if you already have a US brokerage relationship, you want everything in a single dollar bucket, your total US-situs exposure (ASML ADR plus US stocks plus US-domiciled ETFs) will comfortably stay under the $60,000 estate-tax line, or you are holding tactically rather than for decades. For a small, short-horizon position the estate-tax point is largely academic.

Avoid the trap of "the ADR is simpler so I'll just buy that." It is simpler to open, but for a large long-term holding it quietly imports a US estate-tax problem that the Amsterdam line does not have. Simplicity at purchase is not the same as simplicity at inheritance.

ASML in context: the rest of the Dutch large-cap menu

ASML is the marquee name, but it is not the only Dutch business an Indian investor might want. Several other large Dutch companies offer both a home listing and a US route:

• Heineken — Amsterdam listing plus the HEINY ADR in the US.
• Prosus — Amsterdam-listed tech holding company (its dividends carry the same 15% Dutch withholding, including on its US-traded receipts).
• Shell — relocated its primary listing and dual-lists; carries its own withholding profile.
• Philips (PHG) and NXP Semiconductors (NXPI) — both have prominent US listings.

The Amsterdam-versus-US logic in this guide applies to each of them: the dividend tax is Dutch, the estate-tax situs depends on which line you hold, and the long-term holder usually wants the home listing. If your interest is in the index rather than single names, our companion piece on AEX blue-chip ETFs for Indians covers the basket route, and for the global-fund building blocks that also list in Amsterdam, see UCITS ETFs from Amsterdam.

For the broader picture of how the Dutch market fits into a globally diversified Indian portfolio — alongside Germany and France as the European peers — start at the Netherlands market hub or browse the full markets directory.

The bottom line

ASML is one of the few single stocks genuinely worth owning directly for a thematic, long-horizon Indian investor — the lithography monopoly is a structural position in the semiconductor supply chain that no broad index gives you in concentrated form. When you buy it, the dividend math is the same on either line: 15% Dutch withholding, recoverable as an Indian FTC via Form 67, with Indian capital-gains tax of 12.5% after two years. The decision that actually moves the needle is estate-tax situs. For a position you plan to hold and pass on, buy the Amsterdam line and keep ASML out of the US estate-tax system. For a small or tactical position, the ADR's convenience is a fair trade. Either way, file your Schedule FA, mind your LRS limit, and treat ASML as the long-term core holding it deserves to be.

---

This is general information, not tax or investment advice. Dividend withholding, treaty rates, and estate-tax situs rules are technical areas that turn on your specific facts; figures reflect rules as understood in early 2026 and can change. Confirm the current position with a qualified cross-border advisor before committing a large position.